Reports Summarize Acute Lymphoblastic Leukemia Study Results from University of Birmingham (The glutamate/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival).
Předmět: | |
---|---|
Zdroj: | Hematology Week; 7/2/2024, p2136-2136, 1p |
Abstrakt: | A recent report from the University of Birmingham discusses the findings of a study on T-cell acute lymphoblastic leukemia (T-ALL), a type of cancer that affects the immune system. The researchers aimed to identify new therapeutic targets for T-ALL treatment by analyzing gene expression and metabolism in T-ALL cells. They discovered that glutamine uptake is crucial for T-ALL cell proliferation and that the glutamate-aspartate transporter EAAT1 plays a key role in converting glutamine to aspartate and nucleotides. The study concludes that EAAT1 could be a potential therapeutic target for T-ALL treatment. [Extracted from the article] |
Databáze: | Complementary Index |
Externí odkaz: |